Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
If you notice symptoms like rash, itching, swelling, or hives, stop taking the medication and seek medical attention promptly
Human chorionic gonadotropin dosing depends on your individual needs, such as whether you need it to enhance fertility, testicular size, testicular function or your current testosterone levels
This mechanism regulates epithelial cell polarization, which plays an important role to maintain physiological functions, such as tissue barrier and gas exchange in healthy epithelial cells
Targeting adipokines: A new strategy for the treatment of myocardial fibrosis